rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    AZTR
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Azitra, Inc. to Present Research at BIO-Europe® Showing ATR-COSF Reduced Fine Lines and Improved Elasticity in Ex Vivo Human Skin Models
      Nov 10Yahoo FinanceAZTR
      Azitra expands trial eligibility for ATR-04 skin rash treatment
      Oct 29Investing.comAZTR
      Azitra, Inc. Expands Eligibility for ATR-04 Phase 1/2 Clinical Trial to Include Patients with Rashes due to KRAS and MEK Inhibitors
      Oct 29Yahoo FinanceAZTR
      Azitra reports cosmetic product reduces wrinkles in skin study
      Oct 26Investing.comAZTR
      Azitra, Inc. Announces Revitalizing Results from Ex Vivo Study of ATR-COSF Demonstrating Ability to Reduce Fine Lines and Improve Elasticity in Human Skin
      Oct 26Yahoo FinanceAZTR
      Azitra Announces Reverse Stock Split and Share Consolidation

      Detailed price information for Azitra Inc (AZTR-A) from The Globe and Mail including charting and trades.

      Oct 23The Globe and MailAZTR
      Azitra announces 1-for-10 reverse stock split effective Oct. 26
      Oct 16Investing.comAZTR
      Azitra advances skin rash treatment trial to second cohort
      Oct 1Investing.comAZTR
      Azitra, Inc. Advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2 Following Safety Review Committee Clearance
      Oct 1Yahoo FinanceAZTR
      Azitra Launches At-the-Market Equity Offering Program

      Detailed price information for Azitra Inc (AZTR-A) from The Globe and Mail including charting and trades.

      Sep 29The Globe and MailAZTR
      Azitra at H.C. Wainwright conference: pipeline leans on skin bacteria
      Sep 11Investing.comAZTR
      Azitra to Present Corporate Update at Investment Conference

      Detailed price information for Azitra Inc (AZTR-A) from The Globe and Mail including charting and trades.

      Sep 9The Globe and MailAZTR
      Azitra, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference
      Sep 8Yahoo FinanceAZTR
      Azitra Regains NYSE American Listing Compliance Status

      Detailed price information for Azitra Inc (AZTR-A) from The Globe and Mail including charting and trades.

      Aug 22The Globe and MailAZTR
      Azitra regains compliance with NYSE American listing standards
      Aug 21Investing.comAZTR
      Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards

      Azitra, Inc. ("Azitra" or the "Company") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology and high value cosmetic proteins and peptides, today announced that it has received written notification from NYSE American LLC ("NYSE American") confirming that the Company has regained compliance with all of the NYSE American continued listing standards set forth in Part 10 of the NYSE American Company Guide.

      Aug 21Yahoo FinanceAZTR

      This is the newest page. Registered accounts read further back.